Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies

Renaud La Joie, Jeffrey L. Cummings, Jeffrey L. Dage, Douglas Galasko, Milos D. Ikonomovic, Thomas K. Karikari, Susan M. Landau, Jorge J. Llibre-Guerra, Catherine J. Mummery, Rik Ossenkoppele, Julie C. Price, Shannon L. Risacher, Ruben Smith, Christopher H. van Dyck, Maria C. Carrillo.